1. Home
  2. CISO vs HIND Comparison

CISO vs HIND Comparison

Compare CISO & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CISO Global Inc.

CISO

CISO Global Inc.

HOLD

Current Price

$0.19

Market Cap

13.2M

Sector

Technology

ML Signal

HOLD

Logo Vyome Holdings Inc.

HIND

Vyome Holdings Inc.

HOLD

Current Price

$1.87

Market Cap

15.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CISO
HIND
Founded
2015
2017
Country
United States
United States
Employees
N/A
2
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
13.2M
15.2M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
CISO
HIND
Price
$0.19
$1.87
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $8.83
AVG Volume (30 Days)
★ 189.8K
7.9K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 79.31
64.86
EPS
★ N/A
N/A
Revenue
N/A
★ $319,714.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$82.65
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 24.43
52 Week Low
$0.16
$1.75
52 Week High
$1.23
$6.56

Technical Indicators

Market Signals
Indicator
CISO
HIND
Relative Strength Index (RSI) 45.70 26.95
Support Level N/A N/A
Resistance Level $0.26 $2.31
Average True Range (ATR) 0.02 0.07
MACD 0.00 -0.02
Stochastic Oscillator 59.12 0.00

Price Performance

Historical Comparison
CISO
HIND

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity compliance and is a software firm composed of trained and seasoned security professionals. The services are used to protect clients' data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in the U.S., Chile, and all other countries. The maximum revenue is generated from the U.S. The products and services include: security managed services, professional services, and cybersecurity software.

About HIND Vyome Holdings Inc.

Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.

Share on Social Networks: